Research & Discovery
The latest research news in genetics and genomics.
Samsung Invests $10M in Alzheimer's Dx Firm C2N Diagnostics
St. Louis-based C2N said it will use the funds to scale its clinical laboratory services and Alzheimer's testing capabilities.
Neurology Blood Tests Primed to Improve Diagnosis, Management of Patients in Alzheimer's and Beyond
Premium
Such tests are increasingly moving beyond their origins in cutting-edge research and into the laboratory and diagnostic mainstream.
Proteomics International Opens US CLIA Laboratory
The company will use the lab to run its PromarkerD proteomic blood test for identifying individuals at risk of diabetes-related chronic kidney disease.
The group recently published a case-control study showing high sensitivity and specificity, with little drop in early-stage disease, compared to late-stage cancer.
Pro forma revenues, including revenues from SomaLogic, which the firm acquired last January, were also down 9 percent.
Feb 11, 2025
Sera Prognostics Prices $50M Stock Offering
Jan 10, 2025
Quanterix to Acquire Akoya Biosciences
Dec 2, 2024